TETRAPHASE PHARMACEUTICALS INC Current Liabilities
TETRAPHASE PHARMACEUTICALS INC had Current Liabilities of $8.14 million as of 2020-03-31, per its 10-Q filed 2020-05-07.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2020-05-07
- 2020-03-31: Liabilities, Current $8.14M.
- 2019-12-31: Liabilities, Current $9.77M.
- 2019-09-30: Liabilities, Current $11.82M.
- 2019-06-30: Liabilities, Current $19.19M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2020-03-31 | $8.14M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $9.77M 10-Q · filed 2020-05-07 | |
| 2019-09-30 | $11.82M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $19.19M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $13.35M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $14.97M 10-K · filed 2020-03-12 | $14.96M 10-K · filed 2019-03-15 |
| 2018-09-30 | $14.40M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $10.96M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $17.20M 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $18.52M 10-K · filed 2019-03-15 | |
| 2017-09-30 | $22.56M 10-Q · filed 2017-11-01 | |
| 2017-06-30 | $20.59M 10-Q · filed 2017-08-02 | |
| 2017-03-31 | $16.22M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $11.49M 10-K · filed 2018-03-06 | |
| 2016-09-30 | $10.91M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $10.35M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $10.24M 10-Q · filed 2016-05-04 | |
| 2015-12-31 | $10.70M 10-K · filed 2017-03-13 | |
| 2015-09-30 | $10.64M 10-Q · filed 2015-11-02 | |
| 2015-06-30 | $15.68M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $15.68M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $17.28M 10-K · filed 2016-02-25 | |
| 2014-09-30 | $13.17M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $17.27M 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $13.28M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $13.19M 10-K · filed 2015-03-06 | |
| 2013-09-30 | $13.66M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $10.88M 10-Q · filed 2013-08-12 | |
| 2013-03-31 | $9.12M 10-Q · filed 2013-05-13 | |
| 2012-12-31 | $8.66M 10-K · filed 2014-03-06 |